Publication | Closed Access
1215O - SC Neoadjuvant atezolizumab (A) for resectable non-small cell lung cancer (NSCLC): Results from the phase II PRINCEPS trial
88
Citations
0
References
2020
Year
No additional data available for this publication yet. Check back later!